scholarly journals The Development of Cancer Patient Navigation Program in Taiwan

2018 ◽  
Vol 4 (Supplement 2) ◽  
pp. 243s-243s
Author(s):  
C.-W. Huang ◽  
C.-Y. Wu ◽  
R. Chen ◽  
T.-H. Huang ◽  
T.-H. Hsu ◽  
...  
Keyword(s):  
Survival Rate ◽  
Case Management ◽  
Cancer Treatment ◽  
Cancer Diagnosis ◽  
Cancer Care ◽  
Patient Navigation ◽  
Relative Survival ◽  
Relative Survival Rate ◽  
Navigation Program ◽  
Cancer Patient Navigation

Background and context: Cancer has been the leading cause of death since 1982 in Taiwan. Taiwan cancer case management program started from major 4 cancers (breast cancer, liver cancer, colorectal cancer, oral cancer) since 2004. However, only 82% of patients with a confirmed cancer diagnosis received their first cancer treatment within 3 months in 2012. Aim: To increase the navigation coverage for all cancer patients, Health Promotion Administration (HPA) sets the goal that 91% of patients with a confirmed cancer diagnosis should receive their first cancer treatment within 3 months in 2018. Strategy/Tactics: (1) Subsidize cancer hospitals (2) Accreditation for oncology case management (3) Pay for performance (P4P) Program/Policy process: We subsidized hospitals to establish oncology case manager since 2004. Gradually, hospitals in Taiwan accept this new nursing role and recognize its positive impacts on cancer care. Moreover, Taiwan Accreditation Program of Cancer Care mandated all cancer care institutes to establish the program for oncology case management since 2010. However, there were only 4-6 major cancer patients got the case management service. Thus HPA launched P4P Cancer Patient Navigation Program in 2014 and established reporting system. Outcomes: 95% of newly cancer diagnosis patients (including 92 hospitals) in Taiwan receive the service and 96% of patients with a confirmed cancer diagnosis receive their first cancer treatment within 3 months in 2017. Through the implementation of subsidy, accreditation and P4P, the relative survival rate showed significant improved. The 5-year relative survival rate for all cancers increases from 49% during 2003-2007% to 55.8% during 2011-2015. What was learned: A successful program might start small from few trial sites, should be fully supported and well established the systems by government and will move fast by all healthcare professionals.

scholarly journals CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016

2019 ◽  
Vol 21 (Supplement_5) ◽  
pp. v1-v100 ◽  
Author(s):  
Quinn T Ostrom ◽  
Gino Cioffi ◽  
Haley Gittleman ◽  
Nirav Patil ◽  
Kristin Waite ◽  
...  
Keyword(s):  
United States ◽  
Central Nervous System ◽  
Nervous System ◽  
Survival Rate ◽  
Incidence Rate ◽  
Relative Survival ◽  
The United States ◽  
Population Based ◽  
Cns Tumors ◽  
Relative Survival Rate

AbstractThe Central Brain Tumor Registry of the United States (CBTRUS), in collaboration with the Centers for Disease Control and Prevention and National Cancer Institute, is the largest population-based registry focused exclusively on primary brain and other central nervous system (CNS) tumors in the United States (US) and represents the entire US population. This report contains the most up-to-date population-based data on primary brain tumors available and supersedes all previous reports in terms of completeness and accuracy. All rates are age-adjusted using the 2000 US standard population and presented per 100,000 population. The average annual age-adjusted incidence rate (AAAIR) of all malignant and non-malignant brain and other CNS tumors was 23.41 (Malignant AAAIR = 7.08, non-Malignant AAAIR = 16.33). This rate was higher in females compared to males (25.84 versus 20.82), Whites compared to Blacks (23.50 versus 23.34), and non-Hispanics compared to Hispanics (23.84 versus 21.28). The most commonly occurring malignant brain and other CNS tumor was glioblastoma (14.6% of all tumors), and the most common non-malignant tumor was meningioma (37.6% of all tumors). Glioblastoma was more common in males, and meningioma was more common in females. In children and adolescents (age 0–19 years), the incidence rate of all primary brain and other CNS tumors was 6.06. An estimated 86,010 new cases of malignant and non-malignant brain and other CNS tumors are expected to be diagnosed in the US in 2019 (25,510 malignant and 60,490 non-malignant). There were 79,718 deaths attributed to malignant brain and other CNS tumors between 2012 and 2016. This represents an average annual mortality rate of 4.42. The five-year relative survival rate following diagnosis of a malignant brain and other CNS tumor was 35.8%, and the five-year relative survival rate following diagnosis of a non-malignant brain and other CNS tumors was 91.5%.

scholarly journals Upaya Peningkatkan Pengetahuan Sadari Keluarga Penderita Kanker Payudara dengan Pendekatan Health Beliefe Model

2018 ◽  
Vol 14 (1) ◽  
pp. 35
Author(s):  
Yuniastini Yuniastini ◽  
Ratna Dewi ◽  
Arif Yulinda
Keyword(s):  
Survival Rate ◽  
Self Efficacy ◽  
Relative Survival ◽  
Perceived Barriers ◽  
Motivating Factors ◽  
Perceived Susceptibility ◽  
Relative Survival Rate ◽  
Perceived Seriousness ◽  
Cues To Action

<p>Kanker payudara banyak terjadi pada wanita. Di Lampung, pada tahun 2014,  jumlah penderita kanker payudara adalah yang tertinggi dan sebagian besar datang pada stadium lanjut.  Stadium kanker payudara saat terdiagnosis berhubungan dengan <em>survival rate</em> yang ditimbulkan oleh kanker tersebut. Semakin dini stadium kanker terdiagnosis maka semakin banyak penderita dengan daya tahan hidup selama lima tahun <em>(five-year relative survival rate)</em>. Tujuan penelitian ini meningkatkan pengetahuan tentang kanker payudara dan sadari keluarga penderita  kanker payudara dengan pendekatan <em>Health Beliefe Model </em>(HBM).Penelitian dirancang dengan pendekatan <em>One Group </em><em>Pretest-Posttest</em>.Sampel penelitian adalah sebagian dari keluarga pasien kanker payudara dengan  kriteria:  merupakan keluarga pasien kanker payudara dari satu garis keturunan, berjenis kelamin perempuan, berusia ≥ 20 tahun, dalam kondisisehat dan bersedia berpartisipasi dalam penelitian berjumlah 30 orang. Media yang digunakan video, dirancang dengan pendekatan HBM, yakni dengan memasukkan konstruksi dari HBM yakni <em>perceived seriousness, perceived susceptibility</em>, <em>perceive benefits,perceived barriers, cues to action, motivating factors</em>, <em>self-efficacy</em>. Pengetahuan yang ditayangkan dalam media meliputi pengertian,  tanda dan gejala kanker payudara, faktor resiko kanker payudara, manfaat sadari dan teknik sadari.Analisis yang digunakan  <em>Wilcoxon Signed Ranks Test</em><em>.</em>Hasil penelitian diperoleh adanya  perbedaan antara pengetahuan keluarga penderita kanker payudara sebelum dan sesudah diberikan perlakuan dengan pendekatan HBM (<em>p</em>=0,000 ; positive ranks 22). <em>Kesimpulan, </em>pendekatan HBM secara signifikan dapat meningkatkan pengetahuan keluarga penderita kanker payudara dan disarankan untuk diterapkan.</p>

Sign in / Sign up

Export Citation Format

Share Document